This investigation demonstrates the direct tumour suppressive function of mindin during colon cancer development through the regulation of the p‐ERK and c‐Fos signalling pathways and cell cycle control in mice, suggesting that mindin can be used as a therapeutic target for CRC. The gene discussed is SPON2; the disease is malignant colon neoplasm.